Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The International Journal of Biological Markers
|
July 13, 2002
Prognostic value of plasminogen activator inhibitors in breast cancer
S Borstnar, I Vrhovec, T Cufer
The International Journal of Biological Markers
|
July 5, 2003
Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer
T Cufer, S Borstnar, I Vrhovec
The Journal of Reproductive Medicine
|
January 1, 1985
Umbilical cord cortisol in breech delivery
T Tomazevic, J Kovacic, I Vrhovec
Journal of Neuro-Oncology
|
July 27, 1999
Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1
M Osmak, I Vrhovec, J Skrk
The International Journal of Biological Markers
|
April 9, 2002
Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival
T Cufer, I Vrhovec, S Borstnar
Clinical Breast Cancer
|
July 19, 2002
Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients
S Borstnar, I Vrhovec, B Svetic, et al.
Clinical and Experimental Obstetrics & Gynecology
|
January 1, 1989
Treatment of ectopic pregnancy with prostaglandin E2
M Ribic-Pucelj, Z Novak-Antolic, I Vrhovec
Neoplasma
|
March 2, 2005
Prognostic and predictive value of cathepsins D and L in operable breast cancer patients
M Jagodic, I Vrhovec, S Borstnar, et al.
Acta Endocrinologica
|
February 1, 1990
Parlodel LAR in the treatment of macroprolactinomas
A Kocijancic, J Prezelj, I Vrhovec, et al.
Pathology, Research and Practice
|
January 1, 1997
Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma
R Golouh, I Vrhovec, M Bracko, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The International Journal of Biological Markers
|
July 13, 2002
Prognostic value of plasminogen activator inhibitors in breast cancer
S Borstnar, I Vrhovec, T Cufer
The International Journal of Biological Markers
|
July 5, 2003
Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer
T Cufer, S Borstnar, I Vrhovec
The Journal of Reproductive Medicine
|
January 1, 1985
Umbilical cord cortisol in breech delivery
T Tomazevic, J Kovacic, I Vrhovec
Journal of Neuro-Oncology
|
July 27, 1999
Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1
M Osmak, I Vrhovec, J Skrk
The International Journal of Biological Markers
|
April 9, 2002
Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival
T Cufer, I Vrhovec, S Borstnar
Clinical Breast Cancer
|
July 19, 2002
Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients
S Borstnar, I Vrhovec, B Svetic, et al.
Clinical and Experimental Obstetrics & Gynecology
|
January 1, 1989
Treatment of ectopic pregnancy with prostaglandin E2
M Ribic-Pucelj, Z Novak-Antolic, I Vrhovec
Neoplasma
|
March 2, 2005
Prognostic and predictive value of cathepsins D and L in operable breast cancer patients
M Jagodic, I Vrhovec, S Borstnar, et al.
Acta Endocrinologica
|
February 1, 1990
Parlodel LAR in the treatment of macroprolactinomas
A Kocijancic, J Prezelj, I Vrhovec, et al.
Pathology, Research and Practice
|
January 1, 1997
Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma
R Golouh, I Vrhovec, M Bracko, et al.
Page
of 3